chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Severe arthritis, back aches, headache, muscle aches, chronic fatigue. GI distress. Pain killers (hydrocodone). Follow up per medical record: back pain, numbness of limbs, lack of concentration, memory loss, joint pains, rash, itching, photo sensitivity, blurred vision.
Booster; Chills; Tired; Body aches; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from a sales representative. The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (MANUFACTURER UNKNOWN), for COVID-19 immunization. The following information was reported: IMMUNISATION (non-serious), outcome "unknown", described as "Booster"; CHILLS (non-serious), outcome "unknown", described as "Chills"; FATIGUE (non-serious), outcome "unknown", described as "Tired"; PAIN (non-serious), outcome "unknown", described as "Body aches".  Additional information: Patient felt chills, tired and body aches after receiving Pfizer booster vaccine. Event took place after use of product.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This patient had a fever, muscle aches, erythema, and pain to the site. Tylenol and Benadryl.
Hospitalization for calcium channel blocker overdose (COVID-19 positive three days later) on dates 8/7/2023-9/4/2023. Treated with dexamethasone, baricitinib, Remdesivir, vitamin C 1,000 mg PO daily, vitamin D 25 mcg PO daily, zinc 50 mg PO daily.
seen 5/21/21 #Cough - Ongoing since 9 May 2021 - Notes cough started after she received her 1st COVID vaccine (Pfizer) - Has been using OTC Mucinex and vic vapor  - + slight chest tightness; denies shortness of breath/wheezing - Denies new medications, proceeding cold symptoms - Denies fever, chills  was prescribed prednisone with some improvement  5/25/21 now has nasal congestion as well.  States she is feeling better today compared to yesterday.  Patient Zarabee's night time to help with cough.  Mucinex with some improvement.  States she has not had COVID testing, states she is quarantine.  Some fatigue.  States chest feels tight, that is improving with prednisone.  Denies fevers, chills, sore throat, chest pain and shortness of breath.  Notes history of having albuterol with allergies.  Notes she dose not currently have rescue inhaler.  States she was advised by provider in VV that if cough getting worse, if chest tightness, or fever she may need Chest x-ray.  Notes she is trying to avoid going to UC due husband.  Denies muscle aches.  Denies sick contact and known exposure to COVID positive person.   Denies wheezing.    Added flonase and albuterol
MOM STATES CHILD HAD HIVES AND A SWOLLEN ARM, INFORMED NURSE TODAY THAT CLIENT HAD MENINGITIS VACCINE ON 8-13-2011 BUT FAILED TO PRESENT TO NURSE AT VISIT ON 8-22-2011.  MOM TOOK CHILD TO LOCAL ER FOR TREATMENT
Vaccine at 3pm, this happened at 11:00pm. So cold, I felt like my bones were in ice.  My hands trembled badly and my teeth chattered because I was so cold.  Nothing got me warm.  I had 5 heavy blankets on me, didnt help.  I fell asleep and woke up at 3:00am and was back to normal.
This spontaneous report was received from a nurse via company representative referring to a female patient in her late 60's. The patient's concurrent conditions and pertinent medical history were reported. In July 2011 (reported as "5 years ago"), the patient was vaccinated with a dose of ZOSTAVAX (dose, lot #, expiration date and route were not reported). Concomitant therapies were not reported. In approximately January 2012 (reported as after "6 months" of received a dose of ZOSTAVAX), the patient developed severe shingles (unspecified location) and was hospitalized. During hospitalization the patient received unspecified treatment. On unknown date, the patient was discharged from the hospital and she had since fully recovered. No product quality complaint was involved. Additional information has been requested.
The Vial was punctured more than 20 times- This was client #25 that received a shot from this vial. No untoward symptoms from the client.
wakes up in the middle of the night having chills, fever and bad headache; wakes up in the middle of the night having chills, fever and bad headache; wakes up in the middle of the night having chills, fever and bad headache; wakes up in the middle of the night having chills, fever and bad headache; This is a spontaneous report from a Pfizer sponsored program. A contactable other hcp 67-year-old male Nurse (patient) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: Unknown), via an unspecified route of administration on Jun2021 (age at the time of vaccination 67-year-old), as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date Jun2021, the patient experienced wakes up in the middle of the night having chills, fever and bad headache. Patient stated, the events had for 2 days. The patient took Tylenol to reduce fever. The outcome for all the events was recovered on an unspecified date 2021.  Information about lot/batch number requested.
Near syncopal episode after administration of 3rd vaccine, HPV9; 10 min duration light headeness, palor, low BP/low HR; resolved with supine posture and time. complete resolution
Burning feeling, shakes - returned to urgent care and was treated - shakes con't for 3 days. Then a rash on neck and face. Still there as of 4-21-2017. Going to allergy Dr. 4-24-2017.
bone pain; pain like bones were freezing; cold sweat; Patient was began to shake; chills; nausea; This spontaneous case was reported by a consumer and describes the occurrence of BONE PAIN (bone pain), FREEZING PHENOMENON (pain like bones were freezing), COLD SWEAT (cold sweat), TREMOR (Patient was began to shake) and CHILLS (chills) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M20A and 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history provided by the reporter.  Concomitant products included OXYBUTYNIN, MAGNESIUM, ZINC, VITAMIN C [ASCORBIC ACID], VITAMIN E [VITAMIN E NOS], CHONDROITIN SULFATE, GLUCOSAMINE HYDROCHLORIDE (OSTEO BI-FLEX [CHONDROITIN SULFATE;GLUCOSAMINE HYDROCHLORIDE]), KRILL OIL, LUTEIN [XANTOFYL], FAMOTIDINE (FAMOTIDINE AMEL), PROGESTERONE and ESTRADIOL for an unknown indication.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In February 2021, the patient experienced BONE PAIN (bone pain), FREEZING PHENOMENON (pain like bones were freezing), COLD SWEAT (cold sweat), TREMOR (Patient was began to shake), CHILLS (chills) and NAUSEA (nausea). At the time of the report, BONE PAIN (bone pain), FREEZING PHENOMENON (pain like bones were freezing), COLD SWEAT (cold sweat), TREMOR (Patient was began to shake), CHILLS (chills) and NAUSEA (nausea) outcome was unknown.            Treatment information was not provided by the reporter.   This case was linked to MOD-2021-336576, MOD-2021-336728 (Patient Link).
He was having loose stools from teething. Then the day of getting the vaccine he had much larger signs of diarrhea. After that it went back down to loose teething stools. Then on 7/11/2022 he woke up with a fever. His diarrhea came back a lot worse. I took him to his doctor and they diagnosed him with another ear infection. He had no cold symptoms and everything else was fine. He has been on antibiotics for it. He is doing much better. He will be getting the ear tube surgery to prevent him from having future ear infections. This is his 6th ear infection in the last 6 months.
Patient is Pregnant; EDD of 05/29/2018 is presently 35 weeks and 6 days; Flu vaccine given on 01/25/2018 & again on 02/22/2018; Called and spoke to Patient who states she has had no adverse reactions to the vaccines.
No adverse reaction but patient incorrectly received Flublok vaccine which is not indicated for under 18.
This spontaneous report as received from a physician refers to a patient of unknown age and gender. The patient's medical history and current conditions were not reported. On 13-APR-2015, the patient was vaccinated with an improperly stored dose of (Merck) VARIVAX (dose, frequency, route of administration, lot# and expiration date were not reported). No adverse effect was reported. Product quality complain (PQC) was not involved. This is one of several reports received from the same reporter. Additional information has been requested.
red mark noticed behind the ear-appears to be a shingle patterson going down trigeminal nerve, painful blisters w/drainage very red;
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose 05/29/21pfizer,Lot# 2nd dose: 06/19/21,Pfizer,Lot#  Diagnosed covid positive:07/29/21 Symptom onset: Exposure: Community exposure Symptoms: Asymptomatic
About 20 minutes after injection, I started having hives and itching, in random spots all over my body. It lasted for several hours.
No actual adverse event.  Patient was 17 years old and didn't meet the minimum requirement for being 18 years.
Yellow fever given about 1:30 pm 9-4-12, morning of 9-6-12 pt noted headache, stiff & tight neck muscles, full ears and eyes hurt. Has been taking ADVIL every 4 hrs. for temporary relief. On 9-6-12 pt was working in garden. No breathing problems, no hives.
Received second vaccine on 2/3/21 and on 2/4/21 developed nausea, vomiting, chills and low grade fever. Presented to the emergency department on 2/7/21 due to refractory nausea and inability to tolerate PO intake. Denies symptoms of epistaxis, hemoptysis, bruising, petechiae, active signs of bleeding. Labs notable for AKI w/ CR of 1.7 (baseline CR 1.0) and cholestatic liver enzyme elevation (AST 144/ALT 237/ALP 295/T bili 6.1/direct bili 4.0) and thrombocytopenia (nadir to 13). Discharged on 2/13/21. Of note, he had 2 similar admissions in June 2018 and Oct 2019 with unrevealing workup of mixed liver injury. All 3 admissions were after some type of viral antigen exposure: June 2018 after shingles vaccine 2nd dose, Oct 2019 with sapovirus gastroenteritis, and current admission after COVID vaccine 2nd dose.
Diagnosed with appendicitis; Severe pain in lower right abdomen; Felt like she had the flu; This spontaneous case was reported by an other health care professional and describes the occurrence of APPENDICITIS (Diagnosed with appendicitis) and ABDOMINAL PAIN LOWER (Severe pain in lower right abdomen) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014C21A and 006B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included HRT since an unknown date. Concurrent medical conditions included Asthma chronic (Mild chronic asthma). Concomitant products included FLUTICASONE PROPIONATE (FLOVENT) and ALBUTEROL [SALBUTAMOL] for an unknown indication.   On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced APPENDICITIS (Diagnosed with appendicitis) (seriousness criteria hospitalization and medically significant). In 2021, the patient experienced ABDOMINAL PAIN LOWER (Severe pain in lower right abdomen) (seriousness criterion hospitalization) and INFLUENZA LIKE ILLNESS (Felt like she had the flu). The patient was hospitalized on sometime in April 2021 due to APPENDICITIS. The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at a dose of 1 dosage form and Surgery (Appendectomy) for Appendicitis. At the time of the report, APPENDICITIS (Diagnosed with appendicitis), ABDOMINAL PAIN LOWER (Severe pain in lower right abdomen) and INFLUENZA LIKE ILLNESS (Felt like she had the flu) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   concomitant therapy included HRT (Hormone replacement therapy). Patient took Albuterol intermittently.  Patient was diagnosed with appendicitis and had an emergency appendectomy 2 days later.  Company Comment : Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested   This case was linked to MOD-2021-313465 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested
Hospitalized 1/9/2022; COVID-19 Positive 1/9/2022; fully vaccinated Admitting Service: Internal Medicine Service Admission Date: 1/9/2022 Discharge Date: 01/14/2022 PRESENTING PROBLEM:  Hypernatremia Upper GI bleed Dehydration, severe AKI (acute kidney injury) Acute cystitis without hematuria COVID-19 virus infection   HOSPITAL COURSE: Patient is a 90 y.o. female with past medical history significant for  chronic obstructive pulmonary disease, chronic hypoxia, CKD stage 3, anxiety, hypertension, recurrent pulmonary emboli dementia who presented emergency department for failure to thrive. Upon arrival to emergency department, patient was slightly tachycardia but other vitals were stable.  Baseline blood work was obtained which was remarkable for sodium of 153, and creatinine 1.84, WBC 23.6, lactic acid 2.8, INR 3.8, troponin of 51 with repeat of 42. UA was obtained which was positive for acute infection. COVID PCR was also positive. Patient was given a total of 1.5 L for severe dehydration. EKG showed sinus rhythm with first-degree AV block.  Patient was started on Rocephin. During the hospitalization she was treated with D5W which helped improved hypernatremia, sodium level improved, required oxygen intermittently during nighttime, received dexamethasone for couple of days, mental status improved back to baseline, evaluated by PT and OT initially recommended skilled nursing facility but later changed recommendation to home care, recommended continuing home dose of Coumadin, and INR checked with PCP in 1 week. Care Management arranged for home physical therapy and nursing, discharge home today in stable condition, instruction discussed in detail with patient's DPOA son over the phone he verbalized understanding.
Pt had redness to forehead and complained of nausea, shortly after dizziness, sweating, blurred vision with chest pain and all over not feeling well, could not hold head up, EMS called. Pt was given Epi-pen to right thigh and Benadryl 25mg IM to right deltoid approx 7min later. Pt transported by ambulance to hospital.
33 y/o F w/ PMH significant for metastatic breast cancer w/ diffuse osseous lesions and hypercalcemia who presented to the ED w/ nausea, vomiting, and pain.  Pt stated that yesterday she started experiencing nausea and vomiting. Pt took metoclopramide for the nausea, which helped a little. Pt had 5-10 episodes of vomiting with PO intake. pt denies hematemesis or coffee ground emesis, pt endorses minimum bilious emesis, mainly food. Pt additionally states she is having severe generalized pain. This is her typical to her usual pain, however worsened given pt was not able to take PO pain medications. Pt stated her pain was 10/10 in the AM and was 8/10 on presentation. Pain was 6/10 during exam after pt received IV dilaudid.  Pt denies SOB, abdominal pain, chest pain, fever, cough, chills, sick contacts
101 fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (101 fever) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (101 fever). At the time of the report, PYREXIA (101 fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101 (High) 101.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment drug information provided. No concomitant drug information provided.
Mild rash covering abdomen, back, sides of trunk (bilateral), armpits (bilateral), inside of upper thighs (bilateral), left lower arm
Patient's mother relates that patient got her 1st COVID vaccine on Thursday, 11/18/2021, along with her other siblings. On Friday, 11/19/2021, she was feeling tired and achy and she gave her a dose of Ibuprofen. Then on Saturday, 11/20/2021, patient woke up with swelling to the right side of her face and her upper gums. Patient's mother called and spoke with a provider at a prompt care and was encouraged to bring patient to an ER. Patient was brought to the ED on 11/20/21 after giving her a dose of Benadryl at home. Patient's mother relates that patient was discharged from the ED with instructions to continue Benadryl and cool compresses. The ED notes state that patient had minimal swelling to the right eyelid and the upper gums and had no swelling to the tongue, lips, or pharynx and was  not having any difficulty with breathing. Patient's mother relates that patient is doing better and has not had to have any Benadryl since Sunday, 11/21/2021.
Received shot on 4/1/21 and on 4/13/21 in the pm I started to experience a loud noise in my left ear like a roaring sound and on 4/14/21 the noise was intensyfying I contacted my MD (ENT) office as soon as they opened and received an appointment. My hearing has dropped some in the left ear according to the hearing test and I was placed on high dose steroids and a repeat hearing test to be done on 4/22/21. Currently experiencing a whisper of a noise in my left ear.
as of last patient visit, 25 days after the last dose, pain in the left arm with severely reduced range of motion due to pain
swelling in the throat; topper lip was numb; This spontaneous case was reported by a consumer and describes the occurrence of PHARYNGEAL SWELLING (swelling in the throat) and HYPOAESTHESIA ORAL (topper lip was numb) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination.     No medical history information was provided.     On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced PHARYNGEAL SWELLING (swelling in the throat) and HYPOAESTHESIA ORAL (topper lip was numb). The patient was treated with ACRIVASTINE (BENADRYL ALLERGY RELIEF) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, PHARYNGEAL SWELLING (swelling in the throat) and HYPOAESTHESIA ORAL (topper lip was numb) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient consulted Melillo r on 18-mar-2021 Concomitant medication information not provided.
Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medication reported.  It was reported that there had been no power outages that would have impacted the Moderna vaccine. However, the Healthcare professional reiterates that because facility was unable to download the digital data logger, they would need to treat this issue as a temperature excursion. The data logger was unable to download for the months of Dec-2021, Jan-2022, and Feb-2022. They were filling out a temperature excursion assessment with the State at that time. It was reported that no adverse reactions were reported by any patients.  No Treatment medication reported.
4" x 3" area of redness and warmth with central induration and tenderness.
01/19/22 presents to ED for "gross hematuria". PMHx of "BPH, status post TURP, hypertension, diabetes"
This spontaneous report as received from a registered nurse via a company representative and a physician refers to a 63 year old female patient with hydrochlorothiazide allergy and medical history of chickenpox as a child. Patient historical drug included meloxicam, SINGULAIR, XYZAL, bupropion hydrochloride, acetaminophen, LORTAB, ibuprofen and indomethacin. On 11-JAN-2012 the patient was vaccinated with ZOSTAVAX (lot# was reported as 00006496300) in left deltoid (dose and route not reported). Concomitant therapies included LYRICA, BENICAR, NEXIUM, NIFEDICAL XL, PREMARIN, torsemide, meloxicam, PROCARDIA XL, azithromycin and bupropion hydrochloride. There was no rash at the site of injection post-vaccination. On 06-MAY-2014 the patient had painful rash over the right breast around to back, abdomen and flank. Patient also had numerous rash at right upper thorax, back and flank, herpes zoster at right upper thorax and back, right flank with erythematous rash over abdomen and vesicles and dark pigmented lesions. The patient was diagnosed with shingles (The AE onset date was also reported as 03-MAY-2014). The patient didn't have recent VZV exposure to chickenpox or shingles. The patient sough medical attention via office visit on 06-MAY-2014. Since the same day the patient received the following treatment: VALTREX 500mg oral tablet one po tid and ULTRAM 50mg oral tablet one po every 8 hours prn for pain. The outcome of the adverse event was reported as not recovered. Additional information has been requested.
10/31/06 complained of bouts of dizziness and head hurting to mother.  11/3/06 Mother called to report.